secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001140361-25-032503
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology files routine corporate presentation update; no material new information disclosed
--------------------------------------------------------------------------------

- Company updated its investor presentation deck on August 25, 2025 (Exhibit 99.1).
- The filing contains no new financial results, clinical data, or guidance changes.
- Presentation covers previously announced precision oncology pipeline, no new milestones.
- No material events such as earnings, M&A, regulatory actions, or leadership changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/0001140361-25-032503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125032503/ef20054434_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-032503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer